Cefdinir Capsule
Product Images NDC 87063-345

2 FDA label images from Asclemed Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 87063-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Cefdinir (Image 1)

Chemical Structure For Cefdinir (Image 1)
Chemical structure of the active ingredient Cefdinir, showing its molecular framework including thiazole and beta-lactam rings.*
FDA Label Image

1 (Label)

1 (Label)
Labels for Cefdinir Capsules USP 300 mg in capsule form, with quantities of 30, 60, 90, and 100 count packages. The labels show packaging and relabeling by Enovachem Pharmaceuticals, with manufacturing by Teva Pharmaceuticals USA. Each label includes a lot number placeholder, storage instructions, barcodes, and the NDC codes 87063-345-30, 87063-345-60, 87063-345-90, and 87063-345-01 respectively.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.